PURPOSE: A positron emission tomography (PET) tracer for the enzyme phosphodiesterase 10A (PDE10A) is desirable to guide the discovery and development of PDE10A inhibitors as potential therapeutics. The preclinical characterization of the PDE10A PET tracer [(11)C]MK-8193 is described. PROCEDURES: In vitro binding studies with [(3)H]MK-8193 were conducted in rat, monkey, and human brain tissue. PET studies with [(11)C]MK-8193 were conducted in rats and rhesus monkeys at baseline and following administration of a PDE10A inhibitor. RESULTS: [(3)H]MK-8193 is a high-affinity, selective PDE10A radioligand in rat, monkey, and human brain tissue. In vivo, [(11)C]MK-8193 displays rapid kinetics, low test-retest variability, and a large specific signal that is displaced by a structurally diverse PDE10A inhibitor, enabling the determination of pharmacokinetic/enzyme occupancy relationships. CONCLUSIONS: [(11)C]MK-8193 is a useful PET tracer for the preclinical characterization of PDE10A therapeutic candidates in rat and monkey. Further evaluation of [(11)C]MK-8193 in humans is warranted.
PURPOSE: A positron emission tomography (PET) tracer for the enzyme phosphodiesterase 10A (PDE10A) is desirable to guide the discovery and development of PDE10A inhibitors as potential therapeutics. The preclinical characterization of the PDE10A PET tracer [(11)C]MK-8193 is described. PROCEDURES: In vitro binding studies with [(3)H]MK-8193 were conducted in rat, monkey, and human brain tissue. PET studies with [(11)C]MK-8193 were conducted in rats and rhesus monkeys at baseline and following administration of a PDE10A inhibitor. RESULTS: [(3)H]MK-8193 is a high-affinity, selective PDE10A radioligand in rat, monkey, and human brain tissue. In vivo, [(11)C]MK-8193 displays rapid kinetics, low test-retest variability, and a large specific signal that is displaced by a structurally diverse PDE10A inhibitor, enabling the determination of pharmacokinetic/enzyme occupancy relationships. CONCLUSIONS: [(11)C]MK-8193 is a useful PET tracer for the preclinical characterization of PDE10A therapeutic candidates in rat and monkey. Further evaluation of [(11)C]MK-8193 in humans is warranted.
Authors: Paul Morgan; Piet H Van Der Graaf; John Arrowsmith; Doug E Feltner; Kira S Drummond; Craig D Wegner; Steve D A Street Journal: Drug Discov Today Date: 2011-12-29 Impact factor: 7.851
Authors: Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson Journal: J Cereb Blood Flow Metab Date: 2007-05-09 Impact factor: 6.200
Authors: Izzat T Raheem; Michael J Breslin; Christine Fandozzi; Joy Fuerst; Nicole Hill; Sarah Huszar; Monika Kandebo; Somang H Kim; Bennett Ma; Georgia McGaughey; John J Renger; John D Schreier; Sujata Sharma; Sean Smith; Jason Uslaner; Youwei Yan; Paul J Coleman; Christopher D Cox Journal: Bioorg Med Chem Lett Date: 2012-07-27 Impact factor: 2.823
Authors: Renee C Gentzel; Dawn Toolan; Rhonda Roberts; Amy Jo Koser; Monika Kandebo; James Hershey; John J Renger; Jason Uslaner; Sean M Smith Journal: Neuropharmacology Date: 2015-06-02 Impact factor: 5.250
Authors: Zhude Tu; Jinda Fan; Shihong Li; Lynne A Jones; Jinquan Cui; Prashanth K Padakanti; Jinbin Xu; Dexing Zeng; Kooresh I Shoghi; Joel S Perlmutter; Robert H Mach Journal: Bioorg Med Chem Date: 2011-01-22 Impact factor: 3.641
Authors: Christopher D Cox; Eric D Hostetler; Broc A Flores; Jeffrey L Evelhoch; Hong Fan; Liza Gantert; Marie Holahan; Waisi Eng; Aniket Joshi; Georgia McGaughey; Xiangjun Meng; Mona Purcell; Izzat T Raheem; Kerry Riffel; Youwei Yan; John J Renger; Sean M Smith; Paul J Coleman Journal: Bioorg Med Chem Lett Date: 2015-06-01 Impact factor: 2.823
Authors: M Yamazaki; W E Neway; T Ohe; I Chen; J F Rowe; J H Hochman; M Chiba; J H Lin Journal: J Pharmacol Exp Ther Date: 2001-03 Impact factor: 4.030
Authors: Hang Chen; Dianna Lester-Zeiner; Jianxia Shi; Silke Miller; Charlie Glaus; Essa Hu; Ning Chen; Jessica Able; Christopher Biorn; Jamie Wong; Ji Ma; Klaus Michelsen; Geraldine Hill Della Puppa; Tim Kazules; Hui Hannah Dou; Santosh Talreja; Xiaoning Zhao; Ada Chen; Shannon Rumfelt; Roxanne K Kunz; Hu Ye; Oliver R Thiel; Toni Williamson; Carl Davis; Amy Porter; David Immke; Jennifer R Allen; James Treanor Journal: J Pharmacol Exp Ther Date: 2014-12-11 Impact factor: 4.030
Authors: Barry R Campbell; Dinko Gonzalez Trotter; Catherine D G Hines; Wenping Li; Manishkumar Patel; Weisheng Zhang; Jeffrey L Evelhoch Journal: ILAR J Date: 2016-12
Authors: Hui Liu; Hongjun Jin; Xuyi Yue; Junbin Han; Hao Yang; Hubert Flores; Yi Su; David Alagille; Joel S Perlmutter; Gilles Tamagnan; Zhude Tu Journal: Pharmacol Res Perspect Date: 2016-08-26